163 related articles for article (PubMed ID: 25710812)
1. A pilot study to compare meal-triggered gastric electrical stimulation and insulin treatment in Chinese obese type 2 diabetes.
Wong SK; Kong AP; Luk AO; Ozaki R; Ng VW; Lebovitz HE; Ng EK; Chan JC
Diabetes Technol Ther; 2015 Apr; 17(4):283-90. PubMed ID: 25710812
[TBL] [Abstract][Full Text] [Related]
2. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes.
Bohdjalian A; Ludvik B; Guerci B; Bresler L; Renard E; Nocca D; Karnieli E; Assalia A; Prager R; Prager G
Surg Endosc; 2009 Sep; 23(9):1955-60. PubMed ID: 19067068
[TBL] [Abstract][Full Text] [Related]
3. Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm.
Lebovitz HE; Ludvik B; Yaniv I; Haddad W; Schwartz T; Aviv R;
Diabet Med; 2013 Jun; 30(6):687-93. PubMed ID: 23323566
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.
Li CJ; Li J; Zhang QM; Lv L; Chen R; Lv CF; Yu P; Yu DM
Cardiovasc Diabetol; 2012 Nov; 11():142. PubMed ID: 23153177
[TBL] [Abstract][Full Text] [Related]
5. Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control.
Sanmiguel CP; Conklin JL; Cunneen SA; Barnett P; Phillips EH; Kipnes M; Pilcher J; Soffer EE
J Diabetes Sci Technol; 2009 Jul; 3(4):964-70. PubMed ID: 20144347
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness and safety of liraglutide in clinical practice.
Ponzani P
Minerva Endocrinol; 2013 Mar; 38(1):103-12. PubMed ID: 23435446
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
[TBL] [Abstract][Full Text] [Related]
8. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
Jacober SJ; Scism-Bacon JL; Zagar AJ
Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.
Kuhadiya ND; Malik R; Bellini NJ; Patterson JL; Traina A; Makdissi A; Dandona P
Endocr Pract; 2013; 19(6):963-7. PubMed ID: 23807520
[TBL] [Abstract][Full Text] [Related]
10. Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day.
Kempf K; Schloot NC; Gärtner B; Keil R; Schadewaldt P; Martin S
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():21-7. PubMed ID: 23909831
[TBL] [Abstract][Full Text] [Related]
11. Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.
Viswanathan P; Chaudhuri A; Bhatia R; Al-Atrash F; Mohanty P; Dandona P
Endocr Pract; 2007 Sep; 13(5):444-50. PubMed ID: 17872344
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
Guo W; Tian W; Lin L; Xu X
Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
[TBL] [Abstract][Full Text] [Related]
13. Treatment Patterns and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus Receiving Only Oral Antidiabetes Drugs in China.
Zhang L; Ji L; Guo L; Lu J; Tian H; Zhu D; Xing X; Weng JP; Jia W
Diabetes Technol Ther; 2015 Nov; 17(11):816-24. PubMed ID: 26448574
[TBL] [Abstract][Full Text] [Related]
14. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
15. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
16. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
17. The impact of initiating biphasic human insulin 30 therapy in type 2 diabetes patients after failure of oral antidiabetes drugs.
Gu Y; Hou X; Zhang L; Pan J; Cai Q; Bao Y; Jia W
Diabetes Technol Ther; 2012 Mar; 14(3):244-50. PubMed ID: 22047050
[TBL] [Abstract][Full Text] [Related]
18. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
19. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year.
Nocca D; Guillaume F; Noel P; Picot MC; Aggarwal R; El Kamel M; Schaub R; de Seguin de Hons C; Renard E; Fabre JM
Obes Surg; 2011 Jun; 21(6):738-43. PubMed ID: 21468625
[TBL] [Abstract][Full Text] [Related]
20. Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation.
Bohdjalian A; Prager G; Rosak C; Weiner R; Jung R; Schramm M; Aviv R; Schindler K; Haddad W; Rosenthal N; Ludvik B
Obes Surg; 2009 Sep; 19(9):1221-7. PubMed ID: 19575272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
